Glen Eagle Advisors, LLC Axonics, Inc. Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 50 shares of AXNX stock, worth $3,441. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50Holding current value
$3,441% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AXNX
# of Institutions
241Shares Held
42.8MCall Options Held
73.7KPut Options Held
230K-
Vanguard Group Inc Valley Forge, PA5.04MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.34MShares$299 Million0.01% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.11MShares$145 Million6.8% of portfolio
-
Fil LTD Hamilton, D02.04MShares$140 Million0.14% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny1.77MShares$122 Million2.93% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.38B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...